{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:46:36Z","timestamp":1780321596595,"version":"3.54.1"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.cca.2026.120996","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:00:35Z","timestamp":1774882835000},"page":"120996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel biomarkers for early diagnosis and treatment strategies of diabetic retinopathy: A comprehensive review"],"prefix":"10.1016","volume":"588","author":[{"given":"K.","family":"Saravanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Elavarasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Revathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Karuppannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ashokkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.J. Senthil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2026.120996_bb0005","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0010","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1185\/030079908X297303","article-title":"Direct and indirect costs among employees with diabetic retinopathy in the United States","volume":"24","author":"Lee","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.cca.2026.120996_bb0015","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00019053-200927060-00004","article-title":"Economic outcomes associated with microvascular complications of type 2 diabetes mellitus","volume":"27","author":"Pelletier","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cca.2026.120996_bb0020","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00125-010-1836-3","article-title":"Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden","volume":"53","author":"Heintz","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0025","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.120996_bb0030","series-title":"7th edition | IDF Diabetes Atlas","author":"Cho","year":"2015"},{"key":"10.1016\/j.cca.2026.120996_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0002-9394(86)90069-3","article-title":"Relationship of duration and onset of diabetes to prevalence of diabetic retinopathy","volume":"102","author":"Jerneld","year":"1986","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0168-8227(00)00212-6","article-title":"Risk factors for the development of diabetic retinopathy in japanese type 2 diabetic patients","volume":"51","author":"Yoshida","year":"2001","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.120996_bb0045","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2337\/diacare.26.2.320","article-title":"Longitudinal studies of incidence and progression of diabetic retinopathy assessed by retinal photography in pima indians","volume":"26","author":"Looker","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1464-5491.2009.02870.x","article-title":"Diabetic retinopathy screening: a systematic review of the economic evidence","volume":"27","author":"Jones","year":"2010","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cca.2026.120996_bb0055","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0161-6420(02)01074-6","article-title":"The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study","volume":"109","author":"Klein","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.cca.2026.120996_bb0060","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jama.298.8.902","article-title":"Management of diabetic retinopathy: a systematic review","volume":"298","author":"Mohamed","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2026.120996_bb0065","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"Turner","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2026.120996_bb0070","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1001\/archopht.122.11.1631","article-title":"Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69","volume":"122","author":"Matthews","year":"2004","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0075","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2337\/dc11-0079","article-title":"Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: Meta-analysis of observational studies","volume":"34","author":"Kramer","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0080","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00125-014-3197-9","article-title":"MiR-195 regulates SIRT1-mediated changes in diabetic retinopathy","volume":"57","author":"Mortuza","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2337\/db15-0389","article-title":"Angiogenic microRNAs linked to incidence and progression of diabetic retinopathy in type 1 diabetes","volume":"65","author":"Zampetaki","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0090","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/dc09-0565","article-title":"Advances in the medical treatment of diabetic retinopathy","volume":"32","author":"Sim\u00f3","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0095","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/db14-0930","article-title":"Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC","volume":"64","author":"Lachin","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0100","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2337\/diacare.27.6.1259","article-title":"Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes","volume":"27","author":"McCarter","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1463-1326.2009.01160.x","article-title":"Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature","volume":"12","author":"Nalysnyk","year":"2010","journal-title":"Diabetes Obes. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2026.120996_bb0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.12140","article-title":"Do data in the literature indicate that glycaemic variability is a clinical problem?, Glycaemic variability and vascular complications of diabetes","volume":"15","author":"Cavalot","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.cca.2026.120996_bb0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jmg.2009.073098","article-title":"Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes","volume":"47","author":"Wang","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2026.120996_bb0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00232-003-2038-4","article-title":"Regulation of the expression of the prostate-specific antigen by claudin-7","volume":"194","author":"Zheng","year":"2003","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.cca.2026.120996_bb0125","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1167\/iovs.13-12212","article-title":"Inflammatory biomarkers and progression of diabetic retinopathy in african americans with type 1 diabetes","volume":"54","author":"Roy","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0130","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0034-1372594","article-title":"Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study","volume":"122","author":"Preciado-Puga","year":"2014","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.eye.6702584","article-title":"Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy","author":"Patel","year":"2008","journal-title":"Eye"},{"key":"10.1016\/j.cca.2026.120996_bb0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/IAE.0b013e31816576d5","article-title":"Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease","volume":"28","author":"Murugeswari","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.cca.2026.120996_bb0145","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2007.07.011","article-title":"The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy","volume":"79","author":"My\u015bliwiec","year":"2008","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.120996_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0021-5155(01)00452-X","article-title":"Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema","volume":"46","author":"Shimizu","year":"2002","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00125-004-1628-8","article-title":"Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes - the EURODIAB prospective complications study","volume":"48","author":"Schram","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0160","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-0031-1295491","article-title":"The metabolic role of retinol binding protein 4: an update","volume":"44","author":"Christou","year":"2012","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cca.2026.120996_bb0165","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.120996_bb0170","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.120996_bb0175","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2006-2712","article-title":"Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation","volume":"92","author":"Balagopal","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.120996_bb0180","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1128\/MCB.00820-12","article-title":"Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism","volume":"32","author":"Farjo","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cca.2026.120996_bb0185","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/MCB.00181-15","article-title":"Transgenic mice overexpressing serum retinol-binding protein develop progressive retinal degeneration through a retinoid-independent mechanism","volume":"35","author":"Du","year":"2015","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cca.2026.120996_bb0190","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1046\/j.1523-1755.2000.00996.x","article-title":"Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin","volume":"57","author":"Cheung","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2026.120996_bb0195","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1046\/j.1523-1755.2003.00907.x","article-title":"Production of hemopexin by TNF-alpha stimulated human mesangial cells","volume":"63","author":"Kapojos","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2026.120996_bb0200","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1074\/jbc.271.17.9982","article-title":"The advanced glycation end product, nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions","volume":"271","author":"Fu","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2026.120996_bb0205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.cca.2026.120996_bb0210","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jdiacomp.2014.03.003","article-title":"Correlation between diabetic retinopathy severity and elevated skin autofluorescence as a marker of advanced glycation end-product accumulation in type 2 diabetic patients","volume":"28","author":"Hirano","year":"2014","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.cca.2026.120996_bb0215","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/02713683.2014.918152","article-title":"Relationship of skin autofluorescence to severity of retinopathy in type 2 diabetes","volume":"40","author":"Yasuda","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.cca.2026.120996_bb0220","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1161\/01.ATV.14.10.1521","article-title":"Cellular receptors for advanced glycation end products. Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions","volume":"14","author":"Schmidt","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.cca.2026.120996_bb0225","doi-asserted-by":"crossref","first-page":"43603","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru","year":"2007","journal-title":"Exp. Diabetes Res."},{"key":"10.1016\/j.cca.2026.120996_bb0230","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1006\/mcbr.2000.0243","article-title":"Advanced glycation end products induce blood\u2013retinal barrier dysfunction in normoglycemic rats","volume":"3","author":"Stitt","year":"2000","journal-title":"Mol. Cell Biol. Res. Commun."},{"key":"10.1016\/j.cca.2026.120996_bb0235","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2174\/13816128113199990473","article-title":"Pigment epithelium-derived factor (PEDF) and cardiometabolic disorders","volume":"20","author":"Yamagishi","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.cca.2026.120996_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1037186","article-title":"Advanced glycation end products in diabetic retinopathy and phytochemical therapy","volume":"9","author":"Kang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.cca.2026.120996_bb0245","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(03)00846-9","article-title":"The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a d-domain-like docking site","volume":"550","author":"Ishihara","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2026.120996_bb0250","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1167\/iovs.15-16470","article-title":"Increased plasma S100A12 levels are associated with diabetic retinopathy and prognostic biomarkers of macrovascular events in type 2 diabetic patients","volume":"56","author":"Dong","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0255","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00125-010-1900-z","article-title":"Hyperglycaemia-induced pro-inflammatory responses by retinal m\u00fcller glia are regulated by the receptor for advanced glycation end-products (RAGE)","volume":"53","author":"Zong","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0260","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1167\/iovs.04-1409","article-title":"The RAGE axis in early diabetic retinopathy","volume":"46","author":"Barile","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0265","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1167\/iovs.02-1063","article-title":"The role of advanced glycation end products in retinal microvascular leukostasis","volume":"44","author":"Moore","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0270","first-page":"3156","article-title":"Beneficial effects of a novel RAGE inhibitor on early diabetic retinopathy and tactile allodynia","volume":"17","author":"Li","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.cca.2026.120996_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2011.09.032","article-title":"Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: assay assessment and lower levels in diabetic vs. non-diabetic subjects","volume":"95","author":"Januszewski","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.120996_bb0280","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00125-015-3523-x","article-title":"Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice","volume":"58","author":"McVicar","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0285","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","article-title":"Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries","volume":"129","author":"Sacks","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.120996_bb0290","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/dc10-0793","article-title":"Serum apolipoprotein AI and b are stronger biomarkers of diabetic retinopathy than traditional lipids","volume":"34","author":"Sasongko","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0295","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archopht.1996.01100140281004","article-title":"Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) report 22","volume":"114","author":"Chew","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0300","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/diacare.25.8.1320","article-title":"Blood pressure, lipids, and obesity are associated with RetinopathyThe Hoorn study","volume":"25","author":"Van Leiden","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0305","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.visres.2017.04.010","article-title":"The role of dyslipidemia in diabetic retinopathy","volume":"139","author":"Hammer","year":"2017","journal-title":"Vision Res."},{"key":"10.1016\/j.cca.2026.120996_bb0310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jdiacomp.2014.08.004","article-title":"The predictive role of markers of inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes","volume":"29","author":"Rajab","year":"2015","journal-title":"J. Diabetes Complications"},{"key":"10.1016\/j.cca.2026.120996_bb0315","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc13-1193","article-title":"Association of PAI-1 and fibrinogen with diabetic retinopathy in the veterans affairs diabetes trial (VADT)","volume":"37","author":"Azad","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0320","doi-asserted-by":"crossref","first-page":"304","DOI":"10.2174\/157339910793360815","article-title":"Angiogenic growth factors and their inhibitors in diabetic retinopathy","volume":"6","author":"Praidou","year":"2010","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.cca.2026.120996_bb0325","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/805801","article-title":"The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies","volume":"2014","author":"Han","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cca.2026.120996_bb0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.phrs.2015.05.013","article-title":"Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy","volume":"99","author":"Behl","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cca.2026.120996_bb0335","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1517\/17460441.2013.794781","article-title":"The many facets of PEDF in drug discovery and disease: a diamond in the rough or split personality disorder?","volume":"8","author":"Craword","year":"2013","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.cca.2026.120996_bb0340","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/JOE-14-0065","article-title":"Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy","volume":"222","author":"Elahy","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cca.2026.120996_bb0345","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1042\/CS20130463","article-title":"PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases","volume":"128","author":"He","year":"2015","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.cca.2026.120996_bb0350","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2119\/molmed.2012.00008","article-title":"Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice","volume":"18","author":"Liu","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.cca.2026.120996_bb0355","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-15-0160","article-title":"FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs","volume":"226","author":"Kim","year":"2015","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.cca.2026.120996_bb0360","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.diabres.2015.02.032","article-title":"The role of fibroblast growth factor 21 in diabetes and its complications: a review from clinical perspective","volume":"108","author":"Liu","year":"2015","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cca.2026.120996_bb0365","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/929756","article-title":"Serum fibroblast growth factor 21 levels are correlated with the severity of diabetic retinopathy","author":"Lin","year":"2014","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.cca.2026.120996_bb0370","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00125-015-3652-2","article-title":"Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the fenofibrate intervention and event lowering in diabetes study","volume":"58","author":"Ong","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0375","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1210\/jc.2007-2544","article-title":"Connective tissue growth factor and susceptibility to renal and vascular disease risk in type 1 diabetes","volume":"93","author":"Jaffa","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2026.120996_bb0380","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.2337\/diabetes.53.suppl_3.S16","article-title":"Five stages of evolving Beta-cell dysfunction during progression to diabetes","volume":"53","author":"Weir","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0385","first-page":"649","article-title":"Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients","volume":"21","author":"Brzovi\u0107-\u0160ari\u0107","year":"2015","journal-title":"Mol. Vis."},{"key":"10.1016\/j.cca.2026.120996_bb0390","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1167\/iovs.07-1440","article-title":"Intraretinal leakage and oxidation of LDL in diabetic retinopathy","volume":"49","author":"Wu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0395","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jamaophthalmol.2013.5024","article-title":"Challenges in elucidating the genetics of diabetic retinopathy","volume":"132","author":"Kuo","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0400","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4239\/wjd.v6.i5.715","article-title":"Recent progress in the genetics of diabetic microvascular complications","volume":"6","author":"Chang","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0405","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/10408398.2014.893504","article-title":"Modulatory effects of 1,25-dihydroxyvitamin d3 on eye disorders: a critical review","volume":"57","author":"Nebbioso","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.cca.2026.120996_bb0410","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.gene.2015.04.045","article-title":"Effects of vitamin d receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in han chinese type 2 diabetes patients","volume":"566","author":"Zhong","year":"2015","journal-title":"Gene"},{"key":"10.1016\/j.cca.2026.120996_bb0415","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.0000256837.40544.4a","article-title":"Vascular cell senescence: Contribution to atherosclerosis","volume":"100","author":"Minamino","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.cca.2026.120996_bb0420","first-page":"86","article-title":"Telomeric chromatin: roles in aging, cancer and hereditary disease","volume":"647","author":"McCord","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cca.2026.120996_bb0425","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4227","article-title":"Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis","volume":"349","author":"Haycock","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2026.120996_bb0430","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2350-13-38","article-title":"Circulating leukocyte telomere length is highly heritable among families of Arab descent","volume":"13","author":"Al-Attas","year":"2012","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.cca.2026.120996_bb0435","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diab.43.3.441","article-title":"Relationship between retinal and glomerular lesions in IDDM patients","volume":"43","author":"Chavers","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0440","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1600-0420.1996.tb00714.x","article-title":"Glycoprotein deposition in vascular walls of diabetic retinopathy a histopathological and immunohistochemical study","volume":"74","author":"Bek","year":"1996","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.cca.2026.120996_bb0445","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/dmr.5610040404","article-title":"Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy","volume":"4","author":"Williamson","year":"1988","journal-title":"Diabetes Metab. Rev."},{"key":"10.1016\/j.cca.2026.120996_bb0450","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF00418547","article-title":"Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats","volume":"39","author":"Roy","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0455","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2337\/diabetes.55.01.06.db05-0186","article-title":"Effect of combined antisense oligonucleotides against high-glucose\u2013and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability","volume":"55","author":"Oshitari","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0460","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1167\/iovs.08-2377","article-title":"Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats","volume":"50","author":"Cherian","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0465","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3346\/jkms.1994.9.4.341","article-title":"Plasma type IV collagen and fibronectin concentrations in diabetic patients with microangiopathy","volume":"9","author":"Lee","year":"1994","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0470","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/(SICI)1098-2825(1997)11:2<110::AID-JCLA7>3.0.CO;2-F","article-title":"Significance of urinary type IV collagen in patients with diabetic nephropathy using a highly sensitive one-step sandwich enzyme immunoassay","volume":"11","author":"Yagame","year":"1997","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.cca.2026.120996_bb0475","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1034\/j.1399-5448.2001.20408.x","article-title":"Detection of serum collagen type IV in children with type 1 (insulin-dependent) diabetes mellitus \u2013 a longitudinal study","volume":"2","author":"Nicoloff","year":"2001","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0480","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diab.40.1.102","article-title":"Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells","volume":"40","author":"Cagliero","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0485","doi-asserted-by":"crossref","first-page":"478","DOI":"10.2337\/diab.43.3.478","article-title":"Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells","volume":"43","author":"Pugliese","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0490","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/bjo.83.9.1056","article-title":"Effect of panretinal photocoagulation on serum levels of laminin in patients with diabetes: a prospective study","volume":"83","author":"Masmiquel","year":"1999","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12177-012-9091-0","article-title":"Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy","volume":"5","author":"Mohammad","year":"2012","journal-title":"J. Ocul. Biol. Dis. Infor."},{"key":"10.1016\/j.cca.2026.120996_bb0500","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/13543784.2012.681043","article-title":"Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9","volume":"21","author":"Kowluru","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.cca.2026.120996_bb0505","first-page":"1","article-title":"Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: The EURODIAB Prospective Complications Study","volume":"14","author":"Peeters","year":"2015","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.cca.2026.120996_bb0510","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1006\/bbrc.1993.1451","article-title":"Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma","volume":"192","author":"Kitamura","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2026.120996_bb0515","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0014-5793(94)00928-7","article-title":"Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma","volume":"352","author":"Sakata","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2026.120996_bb0520","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1006\/bbrc.1994.1827","article-title":"Endothelial cells actively synthesize and secrete adrenomedullin","volume":"201","author":"Sugo","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cca.2026.120996_bb0525","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-0115(03)00027-2","article-title":"Adrenomedullin in the eye","volume":"112","author":"Udono-Fujimori","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.cca.2026.120996_bb0530","first-page":"138","article-title":"Adrenomedullin, a multifunctional regulatory peptide","volume":"21","author":"Hinson","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cca.2026.120996_bb0535","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000068244","article-title":"Elevated adrenomedullin in the vitreous of patients with diabetic retinopathy","volume":"217","author":"Ito","year":"2003","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.cca.2026.120996_bb0540","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2026.120996_bb0545","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4093\/dmj.2011.35.6.595","article-title":"The relationship among homocysteine, bilirubin, and diabetic retinopathy","volume":"35","author":"Cho","year":"2011","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.cca.2026.120996_bb0550","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjophthalmol-2011-301044","article-title":"Plasma, aqueous and vitreous homocysteine levels in proliferative diabetic retinopathy","volume":"96","author":"Lim","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0555","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/CS20070275","article-title":"Homocysteine, S -adenosylmethionine and S -adenosylhomocysteine are associated with retinal microvascular abnormalities: the Hoorn Study","volume":"114","author":"Van Hecke","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cca.2026.120996_bb0560","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/archophthalmol.2009.172","article-title":"The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy. Wisconsin epidemiologic study of diabetic Retinopathy","volume":"127","author":"Klein","year":"2009","journal-title":"Archives Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0565","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2147\/OPTH.S77538","article-title":"Folate status in type 2 diabetic patients with and without retinopathy","volume":"9","author":"Malaguarnera","year":"2015","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.cca.2026.120996_bb0570","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.1999.00788.x","article-title":"Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications","volume":"115","author":"Ahmed","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cca.2026.120996_bb0575","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/dc11-2040","article-title":"High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes","volume":"35","author":"Lopes-Virella","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2026.120996_bb0580","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00006982-199909000-00004","article-title":"Circulating antipericyte autoantibodies in diabetic retinopathy","volume":"19","author":"Attawia","year":"1999","journal-title":"Retina"},{"key":"10.1016\/j.cca.2026.120996_bb0585","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00125-003-1057-0","article-title":"Circulating anti-pericyte autoantibodies are present in type 2 diabetic patients and are associated with non-proliferative retinopathy","volume":"46","author":"Nayak","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2026.120996_bb0590","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20209881","article-title":"Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders","volume":"53","author":"Bruno","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.cca.2026.120996_bb0595","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1373\/clinchem.2004.037168","article-title":"Concentration of circulating rhodopsin mRNA in diabetic retinopathy","volume":"50","author":"Hamaoui","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2026.120996_bb0600","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.cca.2026.120996_bb0605","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12265-012-9368-5","article-title":"MicroRNAs and diabetic complications","volume":"5","author":"Natarajan","year":"2012","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.cca.2026.120996_bb0610","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2337\/db11-0478","article-title":"MiR-146a-mediated extracellular matrix protein production in chronic diabetes complications","volume":"60","author":"Feng","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0615","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2337\/db10-1557","article-title":"MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy","volume":"60","author":"McArthur","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2026.120996_bb0620","series-title":"Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats","author":"Silva","year":"2011"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:49:17Z","timestamp":1778892557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":124,"alternative-id":["S0009898126001786"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120996","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel biomarkers for early diagnosis and treatment strategies of diabetic retinopathy: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120996"}}